Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


Nuclear technology saves lives, especially in Belgium!

Nuclear energy has become a part of our every day lives, but not solely for electricity production. Over the last century, nuclear technology has …


A user experience of Idylla™, the mini-lab

Idylla™, Biocartis’ fully automated molecular diagnostics system was launched in September 2014. Since then, over 100 units have been sold. We ask…

POPULAR TAGS

More screening options for breast and ovarian cancers

Written by AVG on in the category news with the tags , .


Multiplicom releases two new kits for the screening of hereditary breast and ovarian cancer. In addition to the tests for BRCA1 and BRCA2 released in 2012, Multiplicom’s novel assays include a comprehensive 26 gene panel. It allows for a complete germline mutation analysis, including duplications and deletions, determining the risk for breast, ovarian and other hereditary cancers. This is Multiplicom responce to the growing evidence that additional genes carry an increased cancer risks.

The second kit has been specially designed to enable the molecular pathology laboratories to perform testing for BRCA1 and BRCA2 mutations in tumor biopsy material – including formalin fixed paraffin embedded tissue. This is an essential test, in the advent of new treatment options in ovarian cancer using PARP-inhibitors.

Supportive study data for the BRCA Hereditary Cancer MASTR™ Plus kit and the BRCA Tumor MASTR™ Plus kit was presented during the European Human Genetics Conference in Glasgow, June 6 -9.
 

Read more about: , .

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


Nuclear technology saves lives, especially in Belgium!

Nuclear energy has become a part of our every day lives, but not solely for electricity production. Over the last century, nuclear technology has …


A user experience of Idylla™, the mini-lab

Idylla™, Biocartis’ fully automated molecular diagnostics system was launched in September 2014. Since then, over 100 units have been sold. We ask…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

V-Bio Ventures Itera Life Science Turnstone Biowin GSK XpandInnovation Flanders.bio UGent KU Leuven Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.